Robert Billow, DO
Physical Medicine & Rehabilitation · Anacortes, WANPI 1689672552
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Avanos Medical at 49.1% of the total. Reporting peaked in 2022 at $264 and has fallen 58.6% since, to $110 in 2023.
Across 23 payments — averaging $38.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$429
- Vertos Medical, Inc.$107
- Arthrex$90
- SPR Therapeutics, Inc$75
- Bioventus LLC$59
- Abbott$31
- plus $83 from 4 others
What the payments were for
- Food & beverage$875100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 9 | $429 |
| Vertos Medical, Inc. | 2 | $107 |
| Arthrex | 2 | $90 |
| SPR Therapeutics, Inc | 2 | $75 |
| Bioventus LLC | 2 | $59 |
| Abbott | 2 | $31 |
| Relievant Medsystems, Inc. | 1 | $30 |
| Novartis | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERATOR$143
How this compares
$875 in reported general payments places this provider in the 75th percentile of 260 physical medicine & rehabilitation providers in Washington.
See all physical medicine & rehabilitation providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 365 | $8,189 |
| Gabapentin | 488 | $6,454 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 33 | $1,906 |
| Meloxicam | 312 | $1,816 |
| Tramadol Hcl | 255 | $893 |
| Duloxetine Hcl | 26 | $430 |
| Cyclobenzaprine Hcl | 34 | $329 |
| Methylprednisolone | 43 | $267 |
| Diazepam | 90 | $179 |
| Trazodone Hcl | 19 | $147 |
| Pregabalin | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Anacortes
- Nassim RadSeattle$231K
- Nelson HagerTacoma$186K
- Martin ChildersSeattle$170K
- Theodore BrownKirkland$62K
- Angeli MayadevSeattle$51K
- Ronan CahillBellevue$22K
- Karen StanekSpokane$19K
- Beno KuharichSilverdale$17K
- Ib OddersonBellevue$14K
- Wilson ChangIssaquah$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.